NCT07763314已完成不适用
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Cancer in Switzerland Between 2003 and 2022: A Retrospective National Registry Study
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 73,771
- 试验地点
- 1
- 主要终点
- Incidence
研究概览
简要总结
The incidence of early-onset colorectal cancer (EOCRC; patients younger than 50 years) has increased worldwide over recent decades. This study aimed to provide nationwide evidence on surgically treated EOCRC in Switzerland.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 15 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- All patients with colorectal cancer resection in Switzerland between 2003 and 2022.
排除标准
- •incomplete case documentation
- •age under 15 years
- •other hospitals than general or surgical hospitals
- •no index operation
研究组 & 干预措施
Early-onset colorectal cancer
Colorectal cancer in adults younger than 50 years
干预措施: Early-onset colorectal cancer resection (Procedure)
Late-onset colorectal cancer
Colorectal cancer in adults older than 50 years
干预措施: Late-onset colorectal cancer resection (Procedure)
结局指标
主要结局
Incidence
时间窗: 2003 - 2022
Incidence of early-onset colorectal cancer
时间窗: 2003 - 2022
次要结局
- Localization(2003 - 2022)
- Sociodemographic trends(2003 - 2022)
- Mortality(Periprocedural)
- Length of hospital stay(Periprocedural)
- Sociodemographic trends(January 2003 to December 2022)
- Localization of colorectal cancer(2003 - 2022)
研究者
Yanic Ammann
Principal Investigator
Cantonal Hospital of St. Gallen
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A hospital-based study to screen young adults for early-onset colorectal cancer using stool tests and diet-lifestyle assessmentCTRI/2026/01/100731Vedanta Medical Research Foundation690
进行中（未招募）
3 期
A study to evaluate the efficacy, safety and immunogenicity of Bevacizumab in metastatic colorectal cancer patients.CTRI/2024/04/066032CuraTeQ Biologics Private Ltd168
尚未招募
不适用
Why Treatment Delays Matter in Colorectal Cancer?CTRI/2025/07/091604NGSM Institute of Pharmaceutical Sciences424
尚未招募
不适用
A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)Metastatic Colorectal Cancer (CRC)NCT07685236The First Affiliated Hospital with Nanjing Medical University586
招募中
3 期
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerColorectal CancerNCT07525206AbbVie990